The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group

Inclusion Criteria: * Hb: \>8 and \<10 gr/dl * Age: \>18 and \<55 years * Cholesterol: \<300 mg/dl * Triglyceride: \<400 mg/dl * First Transplantation * Protocol of Immunosuppression: CSA + MMF + Prednisolone * Systolic BP: \<14 * Diastolic BP: \<9 Exclusion Criteria: * History of specified cardiac disease * Second Transplantation or more * Hb: \<7gr/dl * The patient needs to infusion of blood * Evidence of local or systemic infection, at the time of EPO injection * Presence of ATN / DGF after transplantation * Presence of emergent hypertension * High risk patients ( Like; PRA\>50%) * Past history of hypersensitivity